Hemiarch vs Extended Arch in Type 1 Aortic Dissection

Last updated: May 15, 2019
Sponsor: University of Calgary
Overall Status: Active - Recruiting

Phase

N/A

Condition

Occlusions

Chest Pain

Cardiovascular Disease

Treatment

N/A

Clinical Study ID

NCT03885635
HEADSTART
  • Ages 18-70
  • All Genders

Study Summary

HEADSTART is a prospective, open-label, non-blinded, multicenter, randomized controlled trial that compares a composite of mortality and re-intervention in patients undergoing hemiarch and extended arch repair for acute DeBakey type 1 aortic dissection. Eligible patients will be randomized to one or the other surgical strategy and clinical and imaging outcome data will be collected over a 3 year follow up period.

Eligibility Criteria

Inclusion

Inclusion Criteria

  1. Emergent surgical repair of Acute DeBakey Type 1 aortic dissection

  2. Age >18 years and <70 years

  3. Operating surgeon believes that both surgeries could be safe and effective

Exclusion Criteria

  1. Hemodynamic instability/shock defined as systolic BP < 90 mm Hg

  2. Previous cardiac surgery with sternotomy or thoracic endograft placement

  3. Aortic arch diameter > 6cm in which a concomitant arch replacement is judged necessary

  4. Procedures deemed to be "salvage operations" where the patient is unlikely to survive hospital discharge.

  5. GCS < 8 for more than 6 hours

  6. History of cirrhosis.

  7. History of chronic renal failure (baseline eGFR < 50)

  8. Metastatic malignancy

  9. Pregnancy

Study Design

Total Participants: 182
Study Start date:
May 15, 2019
Estimated Completion Date:
March 31, 2025

Study Description

DeBakey Type 1 aortic dissections continue to have high operative mortality and morbidity and there is equipoise in available literature with regards to the best operative strategy and patient selection criteria. Hemiarch repair is current standard of care in most centers but extended arch repair is gaining popularity aiming to address early post-operative malperfusion and improve long term aortic remodeling.

HEADSTART is a randomized controlled prospective trial of patients presenting to participating institutes with acute DeBakey 1 aortic dissection. Patients will be enrolled and randomized into one of two groups - 'hemiarch repair' and 'extended arch repair'. Pre-operative, early post-operative and long term follow clinical and CT imaging data will be collated on a centralized database and at a core lab respectively.

Connect with a study center

  • University of Calgary

    Calgary, Alberta T2N2T9
    Canada

    Active - Recruiting

  • Mazankowski Alberta Heart Institute

    Edmonton, Alberta T6G2B7
    Canada

    Site Not Available

  • New Brunswick Heart Centre

    Saint John, New Brunswick E2L4L2
    Canada

    Site Not Available

  • London Health Sciences Centre

    London, Ontario N6A5A5
    Canada

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.